Monocrotaline N-oxide is a pyrrolizidine alkaloid (PA) derivative, specifically the N-oxide form of monocrotaline. It is a natural product and a metabolite of the parent alkaloid monocrotaline, which is found in plants of the *Crotalaria* genus. This compound is of significant interest in biomedical research due to its role in the toxicity and carcinogenicity associated with pyrrolizidine alkaloids. Monocrotaline N-oxide is a key intermediate in the metabolic activation pathway. It is formed in the liver via cytochrome P450-mediated N-oxidation and can be reduced back to the parent pyrrolizidine base in the gut or tissues, leading to the generation of reactive pyrrolic metabolites that cause hepatotoxicity, pulmonary hypertension, and genotoxicity. Consequently, it serves as a crucial reference standard and research tool for studying the mechanisms of PA-induced toxicity, liver injury models, and for the development of detoxification strategies. Its primary application is in pharmacological and toxicological research as a chemical standard. It is used to investigate the metabolic fate, bioactivation, and toxicological profile of pyrrolizidine alkaloids, which are important both from a public health perspective (as contaminants in food and herbal products) and for understanding chemical carcinogenesis.